semaglutide patent expiry india Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Is Reshaping Diabetes Treatment Semaglutide patent expiry in India

When youre tracking your daily protein intake, you can glance at your fridge and instantly calculate how much youve eaten and what you still need

Sugar Free

Retatrutide is gaining attention in the GLP-1 conversation

The prevalence of overweight and obesity continues to rise in the United States and globally at an alarming rate

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)